GL1X · GenesisL1 explorer

MolNFT v1 · #15085 · protein

HIV-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitor

1MTR: “HIV-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitor”. X-ray diffraction, 2 ligands (PI6, SO4), 1 pocket (best druggability 0.72). MolNFT v1 #15085 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1MTR
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
EC
3.4.23.16
UniProt
P03369
Ligands
PI6, SO4
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 protease (EC 3.4.23.16)protein994% helix, 55% strandP03369

Ligands and binding sites

  • PI6 · [1-benzyl-3-(8-sec-butyl-7,10-dioxo-2-oxa-6,9-diaza-bicyclo[11.2.2] heptadeca-1(16),13(17),14-trien-11-ylamino)-2-hydroxy-propyl]-carbamic acid tert-butyl ester · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13380.720.8434PI6

Interfaces

1 interface between chains.

  • A–B · 1836 Ų buried · 34 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (nonstandard).

Compared structures

  • 1MTR · HIV-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.